The Design of Site-Directed Radiopharmaceuticals for Use in Drug Discovery
|
book
|
January 1993 |
Potent Gastrin-Releasing Peptide (GRP) Antagonists Derived from GRP(19-27) with a C-Terminal DPro.PSI.[CH2NH]Phe-NH2 and N-Terminal Aromatic Residues
|
journal
|
February 1994 |
BW2258U89: A GRP receptor antagonist which inhibits small cell lung cancer growth
|
journal
|
January 1995 |
Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists
|
journal
|
March 1992 |
Synthesis, Characterization, and Labeling with 99m Tc/ 188 Re of Peptide Conjugates Containing a Dithia-bisphosphine Chelating Agent
|
journal
|
May 2001 |
Chemical and physical properties of radionuclides
|
journal
|
January 1987 |
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy
|
journal
|
April 1997 |
Vehicles, Chelators, and Radionuclides: Choosing the “Building Blocks” of an Effective Therapeutic Radioimmunoconjugate
|
journal
|
January 1996 |
Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: A new gastrin releasing peptide receptor (GRPr) targeting radiopharma ceutical
|
journal
|
May 2001 |
Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi
|
journal
|
March 1992 |
Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
|
journal
|
December 1994 |
Peptides in Oncology II
|
book
|
January 1993 |
Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors
|
journal
|
September 1994 |
In vitro and in vivo characterization of novel water-soluble dithio-bisphosphine 99mTc complexes
|
journal
|
October 1997 |
The mechanism of receptor-mediated endocytosis
|
journal
|
December 1991 |
Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems
|
journal
|
March 1995 |
Rhenium(V) and Technetium(V) Oxo Complexes of an N 2 N‘S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations
|
journal
|
December 1997 |
Development of an in vitro model for assessing the in vivo stability of lanthanide chelates
|
journal
|
February 2001 |
Comparisons of 105Rh(III) Chloride Complexation with [14]aneNS3, [14]aneN2S2 and [14]aneN4 Macrocycles in Aqueous Solution
|
journal
|
January 1996 |
BW1023U90: A new GRP receptor antagonist for small-cell lung cancer cells
|
journal
|
January 1996 |
Binding, internalization, and processing of bombesin by rat pancreatic acini
|
journal
|
July 1991 |
No carrier added preparations of ‘3 + 1’ mixed-ligand 99mTc complexes
|
journal
|
January 1998 |
Pharmacokinetics of Antibodies and their Radiolabels
|
book
|
January 2018 |
Functional Targets
|
book
|
January 1996 |
Tumour targeting with radiolabelled macrocycle–antibody conjugates
|
journal
|
January 1990 |
Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: Internalization of receptor bound125I-(Tyr4) bombesin by tumor cells
|
journal
|
July 1994 |
Design and development of receptor-avid peptide conjugates for in-vivo targeting of cancer
|
conference
|
July 1999 |